blog about New Guidelines Issued for Avian Flu Testing and Diagnostics

As avian influenza virus (AIV) threats intensify globally, timely and precise diagnosis has become paramount for effective disease control. Particularly for highly pathogenic avian influenza (HPAI), its rapid transmission potential and cross-species infection risks make early detection essential. Real-time quantitative polymerase chain reaction (Real-time PCR) technology, with its high sensitivity, specificity, and rapid response capability, has emerged as the gold standard for detecting AIV RNA. This comprehensive guide details avian influenza PCR (AIPCR) testing protocols, sample collection procedures, and submission guidelines to support research institutions, veterinary diagnostic laboratories, and livestock professionals.

AIPCR utilizes real-time fluorescence quantitative PCR to amplify and monitor specific AIV genomic sequences through targeted primers and probes. By measuring accumulated fluorescence signals, the test qualitatively and quantitatively identifies viral RNA presence. Key advantages include:

• High sensitivity: Detects minimal viral RNA concentrations for early infection diagnosis
• Exceptional specificity: Distinguishes between AIV subtypes/strains through sequence-specific probes
• Rapid processing: Delivers results within hours for timely outbreak response
• Quantitative capability: Correlates fluorescence intensity with viral load for severity assessment

The technology's applications extend beyond poultry to mammals susceptible to AIV infection, including recent HPAI detections in cattle populations where AIPCR proved instrumental for containment. Environmental surveillance may also utilize this method when warranted.

Standard AIPCR testing typically yields results within 1-3 business days after sample receipt. For urgent cases:

• Same-day processing (non-bovine samples): Requires electronic submission of forms and tracking numbers prior to shipment arrival. Samples must reach the laboratory by 11:00 AM Eastern Time on testing day, with all shipping container sides clearly marked with large "X" symbols in black marker.
• Weekend reporting: Available for high-risk cases with significant public health implications.

Proper specimen handling ensures reliable test outcomes:

• Swabs: Use sterile, sealed viral transport tubes with a few drops of saline if specialized medium is unavailable. Bacterial gel transport media are strictly prohibited.
• Respiratory tissues: Place in leak-proof, shatter-resistant sterile containers.

• Swabs: 3-5.5 mL transport medium
• Tissues: Sufficient material for complete nucleic acid extraction

• Maintain RNA integrity through cold chain transport (ice packs or dry ice)
• Expedite delivery to preserve nucleic acid stability

• Label all containers with source, collection date, and animal information
• Complete submission forms with clinical details and contact information
• Non-compliant samples may incur processing delays and additional fees

For large-scale submissions, laboratories recommend advance coordination to ensure adequate resource allocation.

All positive results undergo confirmatory testing at designated reference laboratories. The nucleic acid-targeting methodology employs real-time PCR technology exclusively.

AIPCR testing represents a critical tool in avian influenza surveillance, combining molecular precision with operational efficiency. Adherence to standardized collection, transport, and submission protocols maximizes diagnostic accuracy, forming the foundation for timely outbreak containment and animal health protection. Proactive communication with testing facilities ensures optimal resource utilization, particularly for high-volume or specialized testing needs.